Experimental Hematology
Volume 38, Issue 10 , Pages 877-884.e1 , October 2010

IL-17 is a potent synergistic factor with GM-CSF in mice in stimulating myelopoiesis, dendritic cell expansion, proliferation, and functional enhancement

  • Bainan Liu

      Affiliations

    • Quantumimmunologics, Tampa, Fla., USA
    • ,
  • Weihong Tan

      Affiliations

    • Department of Gynecology, People's Hospital of Guangxi, People's Republic of China
    • ,
  • Adel Barsoum

      Affiliations

    • Quantumimmunologics, Tampa, Fla., USA
    • ,
  • Xiaogang Gu

      Affiliations

    • Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, La., USA
    • ,
  • Kong Chen

      Affiliations

    • Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, La., USA
    • ,
  • Weitao Huang

      Affiliations

    • Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, La., USA
    • ,
  • Alistair Ramsay

      Affiliations

    • Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, La., USA
    • ,
  • Jay K. Kolls

      Affiliations

    • Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, La., USA
    • ,
  • Paul Schwarzenberger

      Affiliations

    • Quantumimmunologics, Tampa, Fla., USA
    • Corresponding Author InformationOffprint requests to: Paul Schwarzenberger, M.D., Quantumimmunologics, Cancer Immunology, 1881 W. Kennedy Boulevard, Tampa, FL 33623-0727

Received 6 May 2010 ,Revised 31 May 2010 ,Accepted 10 June 2010.

References 

  1. Rouvier E, Luciani MF, Mattei MG, Denizot F, Golstein P. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol. 1993;150:5445–5456
  2. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity. 2004;21:467–476
  3. Mosmann TRH, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136:2348–2357
  4. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006;24:179–189
  5. Mangan PR, Harrington LE, O’Quinn DB, et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature. 2006;441:231–234
  6. Lubberts E. The role of IL-17 and family members in the pathogenesis of arthritis. Curr Opin Invest Drugs. 2003;4:572–577
  7. Ishizu T, Osoegawa M, Mei FJ, et al. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain. 2005;128:988–1002
  8. Nielsen OH, Kirman I, Rudiger N, Hendel J, Vainer B. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand J Gastroenterol. 2003;38:180–185
  9. Zhang Z, Zheng M, Bindas J, Schwarzenberger P, Kolls JK. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis. 2006;12:382–388
  10. Schwarzenberger P, La Russa V, Miller A, et al. IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J Immunol. 1998;161:6383–6389
  11. Schwarzenberger P, Huang W, Ye P, et al. Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J Immunol. 2000;164:4783–4789
  12. Yao Z, Fanslow WC, Seldin MF, et al. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity. 1995;3:811–821
  13. Numasaki M, Fukushi J, Ono M, et al. Interleukin-17 promotes angiogenesis and tumor growth. Blood. 2003;101:2620–2627
  14. Numasaki M, Watanabe M, Suzuki T, et al. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol. 2005;175:6177–6189
  15. Steinman RM. Dendritic cells: understanding immunogenicity. Eur J Immunol. 2007;37(Suppl 1):S53–S60
  16. Bender A, Sapp M, Schuler G, Steinman RM, Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods. 1996;196:121–135
  17. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767–811
  18. Zhang X, Munegowda MA, Yuan J, Wei Y, Xiang J. Optimal TLR9 signal converts tolerogenic CD4-8- DCs into immunogenic ones capable of stimulating antitumor immunity via activating CD4+ Th1/Th17 and NK cell responses. J Leukoc Biol. 2010 May 13;[Epub ahead of print.]
  19. Jaffee EM. Immunotherapy of cancer. Ann N Y Acad Sci. 1999;886:67–72
  20. Happel KI, Zheng M, Young E, et al. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J Immunol. 2003;170:4432–4436
  21. Happel KI, Dubin PJ, Zheng M, et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med. 2005;202:761–769
  22. Huang W, La Russa V, Alzoubi A, Schwarzenberger P. Interleukin-17A: a T-cell derived growth factor for murine and human mesenchymal stem cells. Stem Cells. 2006;24:1512–1518
  23. King IL, Kroenke MA, Segal BM. GM-CSF-dependent, CD103+ dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunization. J Exp Med. 2010;207:953–961
  24. Kolls J, Peppel K, Silvia M, Beutler B. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene-transfer. PNAS U S A. 1994;91:215–219
  25. Chakrabarti S, Brechling K, Moss B. Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol Cell Biol. 1985;5:3403–3409
  26. Restifo NP, Bacik I, Irvine KR, et al. Antigen processing in vivo and the elicitation of primary CTL responses. J Immunol. 1995;154:4414–4422
  27. Wang M, Chen PW, Bronte V, Rosenberg SA, Restifo NP. Anti-tumor activity of cytotoxic T lymphocytes elicited with recombinant and synthetic forms of a model tumor-associated antigen. J Immunother Emphasis Tumor Immunol. 1995;18:139–146
  28. Mayer P, Schutze E, Lam C, Kricek F, Liehl E. Recombinant murine granulocyte-macrophage colony-stimulating factor augments neutrophil recovery and enhances resistance to infections in myelosuppressed mice. J Infect Dis. 1991;163:584–590
  29. Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis. 2004;190:624–631
  30. Ye P, Rodriguez FH, Kanaly S, et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med. 2001;194:519–527
  31. Jovanovic DV, Di Battisita JA, Martel-Pelletier J, et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-1 beta and TNF-alpha, by human macrophages. J Immunol. 1998;160:3521
  32. Sergejeva S, Ivanov S, Lotvall J, Linden A. Interleukin-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation. Am J Respir Cell Mol Biol. 2005;33:248–253
  33. Sergejeva S, Linden A. Impact of IL-17 on cells of the monocyte lineage in health and disease. Endocr Metab Immune Disord Drug Targets. 2009;9:178–186
  34. Fossiez F, Djossou O, Chomarat P, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med. 1996;183:2593–2603
  35. Gabrilovich D. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat Rev Immunol. 2004;4:941–952
  36. Kao JY, Gong Y, Chen CM, Zheng QD, Chen JJ. Tumor-derived TGF-beta reduces the efficacy of dendritic cell/tumor fusion vaccine. J Immunol. 2003;170:3806–3811
  37. Menetrier-Caux C, Montmain G, Dieu MD, et al. Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood. 1998;92:4778–4791

PII: S0301-472X(10)00239-0

doi: 10.1016/j.exphem.2010.06.004

Experimental Hematology
Volume 38, Issue 10 , Pages 877-884.e1 , October 2010

Article Tools

* Image Usage & Resolution